The four biotech stories you need to read this morning

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello! Hope you had a restful and reflective long weekend. Today, we talk a lot about regulatory policy — for flu vaccines and for physicians. We also speak with the new NIH director about how she’s finding a balance between government and industry priorities, and explore the feared brain drain from the new, $500 million research initiative that just launched in Kendall Square.

Read the rest…